Literature DB >> 7243421

Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method.

A D Auerbach, B Adler, R S Chaganti.   

Abstract

Fanconi anemia (FA) is characterized by pancytopenia, spontaneous chromosome instability, and a variety of congenital anomalies. Variable phenotype and age of onset of anemia make accurate diagnosis difficult in some patients. We report a cytogenetic method for rapid diagnosis of FA homozygous blood lymphocytes and amniotic fluid cells, and FA heterozygous blood lymphocytes. When treated with 0.1 micrograms/ml of diepoxybutane, affected lymphocytes responded with approximately a 175-fold increase in chromosome breakage compared with that exhibited by similarly treated lymphocytes from normal individuals or patients who manifest some clinical features of FA. The breakage in affected lymphocytes was characterized by multiple complex chromatoid exchanges. Amniotic fluid cells from four fetuses at risk for FA were studied. Three of these were diagnosed as affected and the fourth as normal on the basis of spontaneous and diepoxybutane-induced chromosome breakage. Lymphocytes from FA heterozygotes showed a fourfold increase in chromosome breakage characterized by chromatid exchange when compared with control lymphocytes. Prenatal and postnatal diagnosis of FA and detection of carriers can therefore be performed with ease by making use of the method described here.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7243421

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  41 in total

Review 1.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

2.  Normal red blood cells partially decrease diepoxybutane-induced chromosome breakage in cultured lymphocytes from Fanconi anaemia patients.

Authors:  B Porto; R Sousa; I Malheiro; J Gaspar; J Rueff; C Gonçalves; J Barbot
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

3.  Segregation analysis with uncertain ascertainment: application to Fanconi anemia.

Authors:  A Rogatko; A D Auerbach
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

Review 4.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 5.  Human DNA repair defects.

Authors:  C F Arlett
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

6.  Sister chromatid exchange evaluation as an aid to the diagnosis and exclusion of Fanconi's anaemia by induced chromosome damage analysis.

Authors:  R T Howell
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

7.  Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.

Authors:  M Pulsipher; G M Kupfer; D Naf; A Suliman; J S Lee; P Jakobs; M Grompe; H Joenje; C Sieff; E Guinan; R Mulligan; A D D'Andrea
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

Review 8.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

9.  Two clonal cell populations (mosaicism) in a 46,XY male with mucolipidosis II (I-cell disease)--an autosomal recessive disorder.

Authors:  G H Thomas; C S Miller; K E Toomey; L W Reynolds; M L Reitman; A Varki; A Vannier; K N Rosebaum; W B Bias; B H Schofield
Journal:  Am J Hum Genet       Date:  1982-07       Impact factor: 11.025

Review 10.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.